Germany· DE-A57-f8f2d2d7ead93c4a
Albothyl
A policresulen product containing policresulen, registered in Germany by Orifarm Healthcare A/S. The same ATC class is registered in 4 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Policresulen is registered in 4 of 19 countries.
Countries holding a registration under ATC G01AX03 (policresulen), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 3 of them publish a price we can compare per daily dose
Policresulen · ATC G01AX03
4 / 19 countries
- Finlandprice
- Germany
- Norwayprice
- Polandprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Policresulen
- Manufacturer
- Orifarm Healthcare A/S
- Country
- Germany (DE)
- ATC code
- G01AX03
- ATC class
- Policresulen
- Defined daily dose
- 90 mg, V
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Policresulen in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandLotagen VetByk Gulden Lomberg Chemische Fabrik Gmbh
- NorwayAlbothylTakeda
- PolandAlbothylOrifarm Healthcare A/S
- United StatesALBOTHYLLydia Co., Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Poland · Albothyl
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/46f8cc25-faf9-4d71-b48e-7fd293545ab7 GET /v1/drugs/46f8cc25-faf9-4d71-b48e-7fd293545ab7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Vaginal Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Policresulen",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about policresulen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.